166 related articles for article (PubMed ID: 23831428)
41. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ
J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556
[TBL] [Abstract][Full Text] [Related]
42. Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.
Hartkopf AD; Wagner P; Wallwiener D; Fehm T; Rothmund R
Anticancer Res; 2011 Mar; 31(3):979-84. PubMed ID: 21498725
[TBL] [Abstract][Full Text] [Related]
43. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
[TBL] [Abstract][Full Text] [Related]
44. Circulating tumor cells in lung cancer.
Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P
Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444
[TBL] [Abstract][Full Text] [Related]
45. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.
Cristofanilli M; Hayes DF; Budd GT; Ellis MJ; Stopeck A; Reuben JM; Doyle GV; Matera J; Allard WJ; Miller MC; Fritsche HA; Hortobagyi GN; Terstappen LW
J Clin Oncol; 2005 Mar; 23(7):1420-30. PubMed ID: 15735118
[TBL] [Abstract][Full Text] [Related]
46. [Identification of Circulating Tumor Cell（CTC）in Breast Cancer Patients Using a Newly Established CTC Detecting System].
Nagata T; Ohnaga T; Lu XL; Watanabe T; Hirano K; Okumura T; Tsukada K
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1240-2. PubMed ID: 26489559
[TBL] [Abstract][Full Text] [Related]
47. Circulating cancer cells are potential weapon for future generations.
Dobrila-Dintinjana R
Hepatogastroenterology; 2014; 61(129):5-8. PubMed ID: 24895783
[TBL] [Abstract][Full Text] [Related]
48. NK cells-directed therapies target circulating tumor cells and metastasis.
Dianat-Moghadam H; Mahari A; Heidarifard M; Parnianfard N; Pourmousavi-Kh L; Rahbarghazi R; Amoozgar Z
Cancer Lett; 2021 Jan; 497():41-53. PubMed ID: 32987138
[TBL] [Abstract][Full Text] [Related]
49. Detection of mycoplasma infection in circulating tumor cells in patients with hepatocellular carcinoma.
Choi HS; Lee HM; Kim WT; Kim MK; Chang HJ; Lee HR; Joh JW; Kim DS; Ryu CJ
Biochem Biophys Res Commun; 2014 Apr; 446(2):620-5. PubMed ID: 24637212
[TBL] [Abstract][Full Text] [Related]
50. Circulating Tumor Cells: Applications for Early Breast Cancer.
Martos T; Casadevall D; Albanell J
Adv Exp Med Biol; 2020; 1220():135-146. PubMed ID: 32304084
[TBL] [Abstract][Full Text] [Related]
51. Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions.
Schochter F; Friedl TWP; deGregorio A; Krause S; Huober J; Rack B; Janni W
Cells; 2019 Nov; 8(11):. PubMed ID: 31717458
[TBL] [Abstract][Full Text] [Related]
52. Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancer.
Liang S; Niu L; Xu K; Wang X; Liang Y; Zhang M; Chen J; Lin M
Mol Immunol; 2017 Dec; 92():45-53. PubMed ID: 29040918
[TBL] [Abstract][Full Text] [Related]
53. Exploring Glycan Markers for Immunotyping and Precision-targeting of Breast Circulating Tumor Cells.
Wang D; Liu X; Hsieh B; Bruce R; Somlo G; Huang J; Sambucetti L
Arch Med Res; 2015 Nov; 46(8):642-50. PubMed ID: 26657044
[TBL] [Abstract][Full Text] [Related]
54. By the numbers: does circulating tumor cell enumeration have a role in metastatic breast cancer?
Liu MC
J Clin Oncol; 2014 Nov; 32(31):3479-82. PubMed ID: 25245442
[No Abstract] [Full Text] [Related]
55. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.
Mohme M; Riethdorf S; Pantel K
Nat Rev Clin Oncol; 2017 Mar; 14(3):155-167. PubMed ID: 27644321
[TBL] [Abstract][Full Text] [Related]
56. Peripheral Blood Mononuclear Cell Populations Correlate with Outcome in Patients with Metastatic Breast Cancer.
Larsson AM; Nordström O; Johansson A; Rydén L; Leandersson K; Bergenfelz C
Cells; 2022 May; 11(10):. PubMed ID: 35626676
[TBL] [Abstract][Full Text] [Related]
57. [Phenotypic and functional characteristics of dendritic cells and contents of suppressor cell populations in peripheral blood of breast cancer patients].
Shevchenko YA; Khristin AA; Falaleeva SA; Kurilin VV; Kuznetsova MS; Sidorov SV; Sennikov SV
Vopr Onkol; 2016; 62(4):519-23. PubMed ID: 30475541
[TBL] [Abstract][Full Text] [Related]
58. Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis.
Lo HC; Xu Z; Kim IS; Pingel B; Aguirre S; Kodali S; Liu J; Zhang W; Muscarella AM; Hein SM; Krupnick AS; Neilson JR; Paust S; Rosen JM; Wang H; Zhang XH
Nat Cancer; 2020 Jul; 1(7):709-722. PubMed ID: 35122036
[TBL] [Abstract][Full Text] [Related]
59. Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment.
Noman MZ; Messai Y; Muret J; Hasmim M; Chouaib S
Cancer Microenviron; 2014 Dec; 7(3):153-60. PubMed ID: 25337680
[TBL] [Abstract][Full Text] [Related]
60. Colorectal cancer: seed and soil hypothesis revisited.
Seretis F; Seretis C; Youssef H; Chapman M
Anticancer Res; 2014 May; 34(5):2087-94. PubMed ID: 24778010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
